Van Hauwermeiren Timothy 4
4 · iTeos Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Van Hauwermeiren Timothy
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2021-06-17+16,608→ 0 totalExercise: $26.03Exp: 2031-06-17→ Common Stock (16,608 underlying)
Footnotes (1)
- [F1]This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders.
Signature
/s/ Michel Detheux, as Attorney-in-Fact|2021-06-21